Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Common Stock | Options Exercise | $0 | +1.07K | $0.00 | 1.07K | Jan 4, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Restricted Stock Unit | Options Exercise | $0 | +1.07K | +99.91% | $0.00 | 2.14K | Jan 4, 2022 | Common Stock | 1.07K | Direct | F1, F2, F3, F4 |
Id | Content |
---|---|
F1 | Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). |
F2 | Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company. |
F3 | This RSU award was granted on January 4, 2021. 33% of the RSU vested on January 4, 2022 and the remaining 67% will vest annually over the next two years. |
F4 | The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. |